Monday 10 September 2012

Glycoprotein platelet inhibitors


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Glycoprotein platelet inhibitors prevent platelet adhesion by binding to the glycoprotein IIb/IIIa receptors on the plasma membrane of platelets. They stop the actual substrates of the glycoprotein receptors from binding to the receptor, so inhibit platelets from sticking together to form a thrombus, which can lead to stroke, myocardial infarction or deep vein thrombosis.


Glycoprotein platelet inhibitors are used in patients with angina, after a heart attack, angioplasty or other types of coronary vasculature procedures.

See also

Medical conditions associated with glycoprotein platelet inhibitors:

  • Acute Coronary Syndrome
  • Angina
  • Heart Attack
  • High Risk Percutaneous Transluminal Angioplasty
  • Percutaneous Coronary Intervention

Drug List:

No comments:

Post a Comment